Stephen Johnston, MD, The Royal Marsden Hospital, UK
Final OS Milestone Results of the monarchE Study Revealed – CDK4/6 Inhibitors Usher in a New Era of Clinical Cure for High-Risk HR+/HER2- Early Breast Cancer Patients! Insights on Personalized Adjuvant Treatment Strategies and Future Exploratory Directions.